148 related articles for article (PubMed ID: 2544435)
1. Corticotropin-releasing factor (CRF) stimulation test in normal subjects and patients with Cushing's syndrome.
Zacharieva S; Matrosov P; Stoeva I; Kirilov G
Exp Clin Endocrinol; 1989 Apr; 93(1):19-28. PubMed ID: 2544435
[TBL] [Abstract][Full Text] [Related]
2. [Corticotropin releasing factor as an aid in the diagnosis of Cushing syndrome].
Pirich K; Vierhapper H; Nowotny P
Wien Klin Wochenschr; 1985 Nov; 97(21):806-8. PubMed ID: 2998101
[TBL] [Abstract][Full Text] [Related]
3. CRH in Cushing's syndrome.
Müller OA; Stalla GK; von Werder K
Horm Metab Res Suppl; 1987; 16():51-8. PubMed ID: 2832289
[TBL] [Abstract][Full Text] [Related]
4. The use of CRF-41 in the differential diagnosis of Cushing's syndrome and obesity.
Grossman A; Howlett TA; Kopelman PG
Horm Metab Res Suppl; 1987; 16():62-4. PubMed ID: 2832293
[TBL] [Abstract][Full Text] [Related]
5. The ovine corticotropin-releasing hormone (CRH) stimulation test is superior to the human CRH stimulation test for the diagnosis of Cushing's disease.
Nieman LK; Cutler GB; Oldfield EH; Loriaux DL; Chrousos GP
J Clin Endocrinol Metab; 1989 Jul; 69(1):165-9. PubMed ID: 2543689
[TBL] [Abstract][Full Text] [Related]
6. [Investigation of Cushing's syndrome. The diagnostic value of the dexamethasone suppression test, the metopirone test and the CRF test].
Johannesen O; Jørgensen H; Frey H; Norman N
Tidsskr Nor Laegeforen; 1989 Sep; 109(26):2678-82. PubMed ID: 2554527
[TBL] [Abstract][Full Text] [Related]
7. Bilateral and simultaneous sinus petrosus inferior catheterization in patients with Cushing's syndrome: plasma-immunoreactive-ACTH-concentrations before and after administration of CRF.
Schulte HM; Allolio B; Günther RW; Benker G; Windeck R; Winkelmann W; Reinwein D
Horm Metab Res Suppl; 1987; 16():66-7. PubMed ID: 2832295
[TBL] [Abstract][Full Text] [Related]
8. The use of the corticotropin-releasing hormone test to monitor the recovery of patients with Cushing's disease or Cushing's syndrome due to an adrenal adenoma after adenomectomy.
Hotta MN; Shibasaki T; Suda T; Ling N; Shizume K
Endocrinol Jpn; 1985 Feb; 32(1):113-25. PubMed ID: 2990881
[TBL] [Abstract][Full Text] [Related]
9. Gastric inhibitory polypeptide-dependent cortisol hypersecretion--a new cause of Cushing's syndrome.
Lacroix A; Bolté E; Tremblay J; Dupré J; Poitras P; Fournier H; Garon J; Garrel D; Bayard F; Taillefer R
N Engl J Med; 1992 Oct; 327(14):974-80. PubMed ID: 1325608
[TBL] [Abstract][Full Text] [Related]
10. The antiglucocorticoid and antiprogestin steroid RU 486 suppresses the adrenocorticotropin response to ovine corticotropin releasing hormone in man.
Laue L; Chrousos GP; Loriaux DL; Barnes K; Munson P; Nieman L; Schaison G
J Clin Endocrinol Metab; 1988 Feb; 66(2):290-3. PubMed ID: 2828406
[TBL] [Abstract][Full Text] [Related]
11. [Value of the corticoliberine test in the etiologic diagnosis of Cushing's syndrome].
Tabarin A; San-Galli F; Guérin J; Corcuff B; Manciet G; Lefort G; Latapie JL; Roger P
Presse Med; 1990 Mar; 19(12):557-61. PubMed ID: 2158088
[TBL] [Abstract][Full Text] [Related]
12. Effects of synthetic corticotropin-releasing factor in normal individuals and in patients with hypothalamic-pituitary-adrenocortical disorders.
Jørgensen H; Skare S; Frey H; Hanssen KF; Norman N
Acta Med Scand; 1985; 218(1):79-84. PubMed ID: 2996312
[TBL] [Abstract][Full Text] [Related]
13. CRF in the differential diagnosis of Cushing's syndrome: a comparison with the dexamethasone suppression test.
Grossman AB; Howlett TA; Perry L; Coy DH; Savage MO; Lavender P; Rees LH; Besser GM
Clin Endocrinol (Oxf); 1988 Aug; 29(2):167-78. PubMed ID: 2854761
[TBL] [Abstract][Full Text] [Related]
14. 24-hour serum concentration profile of cortisol in patients with Cushing's disease.
Pirich K; Vierhapper H
Exp Clin Endocrinol; 1988 Mar; 92(3):275-9. PubMed ID: 2855318
[TBL] [Abstract][Full Text] [Related]
15. Effect of metyrapone pretreatment on adrenocorticotropin secretion induced by corticotropin-releasing hormone in normal subjects and patients with Cushing's disease.
Totani Y; Niinomi M; Takatsuki K; Oiso Y; Tomita A
J Clin Endocrinol Metab; 1990 Mar; 70(3):798-803. PubMed ID: 2155255
[TBL] [Abstract][Full Text] [Related]
16. Cerebrospinal fluid immunoreactive corticotropin-releasing hormone and adrenocorticotropin secretion in Cushing's disease and major depression: potential clinical implications.
Kling MA; Roy A; Doran AR; Calabrese JR; Rubinow DR; Whitfield HJ; May C; Post RM; Chrousos GP; Gold PW
J Clin Endocrinol Metab; 1991 Feb; 72(2):260-71. PubMed ID: 1846869
[TBL] [Abstract][Full Text] [Related]
17. Response of pituitary-adrenal axis to corticotrophin releasing hormone in patients with Cushing's disease before and after ketoconazole treatment.
Boscaro M; Sonino N; Rampazzo A; Mantero F
Clin Endocrinol (Oxf); 1987 Oct; 27(4):461-7. PubMed ID: 2830063
[TBL] [Abstract][Full Text] [Related]
18. Corticotropin releasing factor (CRF): diagnostic implications.
Müller OA; Stalla GK; Hartwimmer J; Schopohl J; von Werder K
Acta Neurochir (Wien); 1985; 75(1-4):49-59. PubMed ID: 2986422
[TBL] [Abstract][Full Text] [Related]
19. Endocrine activity of the "silent" adrenocortical adenoma is uncovered by response to corticotropin-releasing hormone.
Hensen J; Buhl M; Bähr V; Oelkers W
Klin Wochenschr; 1990 Jun; 68(12):608-14. PubMed ID: 2165544
[TBL] [Abstract][Full Text] [Related]
20. Pituitary peptides other than ACTH may not be aldosterone secretagogue in primary aldosteronism.
Miyamori I; Koshida H; Matsubara T; Soma R; Takasaki H; Okamoto S; Takeda R
Exp Clin Endocrinol; 1990 Aug; 95(3):323-9. PubMed ID: 2174003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
